Cancer patients living in rural areas of Australia will have better access to treatment services under a new agreement between Baxter Healthcare and Ramsay Health Care.
The two have struck a deal to bring chemotherapy compounding services to more private hospitals across Australia.
Baxter will provide regulated aseptic compounding services to Ramsay’s hospitals through its six compounding pharmacies in the six Australian states.
The partnership will allow Ramsay Health Care to deliver customised services and better treatment outcomes for cancer patients, particularly those in rural and remote areas.
“Baxter is recognised as Australia’s leading TGA licensed compounder and their capacity to meet the needs of our patients, particularly those being treated in our rural and remote facilities, in a timely manner, was a key criteria for us,” Ramsay Pharmacy Chief Executive Officer Peter Giannopoulos said.
Baxter Australia and New Zealand General Manager Steve Flynn said the need to reach patients in rural areas was a key aspect of the agreement.
“Partnerships like this enable us to deliver products of exceptional quality, reliability and safety to a greater number of patients,” Mr Flynn said.
“This improves access to the full range of intravenous chemotherapy in regional areas.”